Rival Must Pay For Infringing AngioScore Cath IP, Jury Told
TriReme Medical Inc. should pay five to 10 percent in royalties on sales of its Chocolate balloon catheter, which allegedly infringes AngioScore Inc.'s patent on a device that expands blocked arteries,...To view the full article, register now.
Already a subscriber? Click here to view full article